The antioxidant was developed at Moscow State University, or MSU, several years ago. The findings were published in the medical journal “Aging.”
In the course of their work, the researchers used special mice with a gene that increased the rate of random mutations in their mitochondria. This led to accelerated aging and death within a year of their birth, while ordinary mice usually live for more than two years.
One hundred days after their birth, the mice were given small doses of SkQ1. After another 100 to 150 days, the control group that hadn't received SkQ1 showed signs of aging, including weight loss, decreased temperature, the spinal condition kyphosis, baldness and a thinning of the skin. Mice treated with SkQ1 either didn't show these symptoms or showed the symptoms much later.
SkQ1 is meant to protect cells from reactive oxygen produced by damaged mitochondria. If the clinical trials are successful, the drug will be available in pharmacies within a few years.